




Instance: composition-en-e32583165e64f7b46ac4a8e9d8029de8
InstanceOf: CompositionUvEpi
Title: "Composition for aloxi Package Leaflet"
Description:  "Composition for aloxi Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp8c6dee4c1c691616095410343bc90da7)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - aloxi"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet</p>
<ol>
<li>What Aloxi is and what it is used for </li>
<li>What you need to know before you are given Aloxi </li>
<li>How you are given Aloxi </li>
<li>Possible side effects </li>
<li>How to store Aloxi </li>
<li>Contents of the pack and other information </li>
</ol>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What aloxi is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What aloxi is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Aloxi contains the active substance palonosetron. This belongs to a group of medicines called 
 serotonin (5HT3) antagonists .  </p>
<p>Aloxi is used in adults, adolescents and children over one month of age to help stop you feeling or 
being sick (nausea and vomiting) when having cancer treatments called chemotherapy. </p>
<p>It works by blocking the action of a chemical called serotonin, which can cause you to feel sick or to 
vomit.  </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take aloxi"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take aloxi"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not take Aloxi if: 
* you are allergic to palonosetron or any of the other ingredients of this medicine (listed in 
section 6). 
You will not be given Aloxi if any of the above apply to you. If you are not sure, talk to your doctor 
or nurse before you are given this medicine.  </p>
<p>Warnings and precautions 
Talk to your doctor or nurse before you are given Aloxi if: 
* you have a blocked bowel or have had repeated constipation in the past<br />
* you have had heart problems or heart problems run in your family, such as changes in your heart 
beat ( QT prolongation ) 
* you have an imbalance of certain minerals in your blood which has not been treated - such as 
potassium and magnesium. </p>
<p>If any of the above applies to you (or you are not sure), talk to your doctor or nurse before you are 
given Aloxi. </p>
<p>Other medicines and Aloxi 
Tell your doctor or nurse if you are taking, have recently taken or might take any other medicines. In 
particular, tell them if you are taking the following medicines: </p>
<p>Medicines for depression or anxiety 
Tell your doctor or nurse if you are taking any medicines for depression or anxiety, including: 
  medicines called SSRIs ( selective serotonin reuptake inhibitors )   such as fluoxetine, 
paroxetine, sertraline, fluvoxamine, citalopram, escitalopram<br />
* medicines called SNRIs ( serotonin noradrenaline reuptake inhibitors )   such as venlafaxine, 
duloxetine (can lead to the development of serotonin syndrome and should be used with caution). </p>
<p>Medicines that can affect your heart beat 
Tell your doctor or nurse if you are taking any medicines that affect your heart beat   this is because 
they could cause a heart beat problem when taken with Aloxi. This includes: 
  medicines for heart problems such as amiodarone, nicardipine, quinidine 
  medicines for infections such as moxifloxacin, erythromycin 
  medicines for serious mental health problems such as haloperidol, chlorpromazine, quetiapine, 
thioridazine<br />
  a medicine for feeling or being sick (nausea and vomiting) called domperidone. 
If any of the above applies to you (or you are not sure), talk to your doctor or nurse before taking 
Aloxi   this is because these medicines could cause a heart beat problem when taken with Aloxi. </p>
<p>Pregnancy 
If you are pregnant or think you might be pregnant, your doctor will not give you Aloxi unless it is 
clearly necessary. This is because we do not know if Aloxi may harm the baby. </p>
<p>Ask your doctor or nurse for advice before being given this medicine if you are pregnant or think you 
might be. </p>
<p>Breast-feeding 
It is not known if Aloxi is found in breast milk. </p>
<p>Ask your doctor or nurse for advice before being given this medicine if you are breast-feeding. </p>
<p>Driving and using machines 
You may feel dizzy or tired after being given this medicine. If this happens, do not drive or use any 
tools or machines. </p>
<p>Aloxi contains sodium 
This medicine contains less than 1 mmol sodium (23 mg) per vial, that is to say essentially  sodium- free . </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take aloxi"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take aloxi"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Aloxi is normally given by a doctor or nurse. 
* You will be given the medicine about 30 minutes before the start of chemotherapy. </p>
<p>Adults 
* The recommended dose of Aloxi is 250 micrograms. 
* It is given as an injection into a vein.  </p>
<p>Children and young people (aged 1 month to 17 years) 
* The doctor will work out the right dose based on bodyweight. 
* The maximum dose is 1500 micrograms. 
* Aloxi will be given as a drip (a slow infusion into a vein). </p>
<p>It is not recommended you are given Aloxi in the days following chemotherapy unless you are going 
to have another chemotherapy cycle. </p>
<p>If you have any further questions on the use of this medicine, ask your doctor or nurse. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. 
The following side effects may happen with this medicine: </p>
<p>Serious side effects 
Tell your doctor straight away if you notice any of the following serious side effects: 
* allergic reaction - the signs may include swelling of the lips, face, tongue or throat, having 
difficulty breathing or collapsing, an itchy, lumpy rash (hives). This is very rare: may affect up to 
1 in 10,000 people. 
Tell your doctor straight away if you notice any of the serious side effects listed above. </p>
<p>Other side effects 
Tell your doctor if you notice any of the following side effects: </p>
<p>Adults 
Common: may affect up to 1 in 10 people 
* headache, feeling dizzy,<br />
* constipation, diarrhoea. </p>
<p>Uncommon: may affect up to 1 in 100 people 
* change in the colour of the vein and veins becoming larger 
* feeling happier than usual or feeling anxious 
* feeling sleepy or trouble sleeping 
* decrease or loss of appetite<br />
<em> weakness, feeling tired, fever or flu like symptoms 
* numbness, burning, prickling or tingling sensations on the skin 
* itchy skin rash<br />
</em> impaired vision or eye irritation<br />
<em> motion sickness<br />
</em> ringing in the ear<br />
<em> hiccups, passing wind (flatulence), dry mouth or indigestion<br />
</em> abdominal (stomach) pain<br />
* difficulty passing water (urinating) 
* joint pain. </p>
<p>Tell your doctor if you notice any of the side effects listed above. </p>
<p>Uncommon side effects shown in tests: may affect up to 1 in 100 people 
* high or low blood pressure 
* abnormal heart rate or lack of blood flow to the heart 
* abnormally high or low levels of potassium in the blood 
* high levels of sugar in the blood or sugar in the urine 
* low levels of calcium in the blood<br />
<em> high levels of the pigment bilirubin in the blood 
* high levels of certain liver enzymes<br />
</em> ECG (electrocardiogram) abnormalities ( QT prolongation ). </p>
<p>Very rare:  may affect up to 1 in 10,000 people 
* Burning, pain or redness at the injection site 
. 
Children and young people 
Common: may affect up to 1 in 10 people 
* headache. </p>
<p>Uncommon: may affect up to 1 in 100 people 
* dizziness 
* jerky body movements<br />
<em> abnormal heart rate <br />
</em> coughing or shortness of breath<br />
* nosebleed 
* itchy skin rash or hives 
* fever 
* pain at the site of infusion. </p>
<p>Tell your doctor if you notice any of the side effects listed above. </p>
<p>Reporting of side effects 
If you get any side effects, talk to your doctor. This includes any possible side effects not listed in this 
leaflet. You can also report side effects directly via the national reporting system listed in Appendix 
V. By reporting side effects you can help provide more information on the safety of this medicine. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store aloxi"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store aloxi"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <ul>
<li>Keep this medicine out of the sight and reach of children. </li>
<li>Do not use this medicine after the expiry date which is stated on the vial and carton after  EXP . 
The expiry date refers to the last day of that month. </li>
<li>This medicine does not require any special storage conditions. </li>
<li>Single use only, any unused solution should be disposed of. </li>
</ul>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Aloxi contains 
* The active substance is palonosetron (as hydrochloride). Each ml of solution contains 
50 micrograms palonosetron. Each vial of 5 ml of solution contains 250 micrograms of 
palonosetron. 
* The other ingredients are mannitol, disodium edetate, sodium citrate, citric acid monohydrate, 
water for injections, sodium hydroxide and hydrochloric acid. </p>
<p>What Aloxi looks like and contents of the pack 
Aloxi solution for injection is a clear, colourless solution and is supplied in a pack of one Type I glass 
vial with chlorobutyl siliconised rubber stopper and aluminium cap, which contains 5 ml of the 
solution. Each vial contains one dose. </p>
<p>Available in packs of 1 vial containing 5 ml of solution. 
Marketing Authorisation Holder and Manufacturer </p>
<p>Helsinn Birex Pharmaceuticals Ltd.,<br />
Damastown,<br />
Mulhuddart,<br />
Dublin 15,<br />
Ireland. </p>
<p>This leaflet was last revised in </p>
<p>Detailed information on this medicine is available on the European Medicines Agency web site: </p>         </div>"""      



Instance: composition-da-e32583165e64f7b46ac4a8e9d8029de8
InstanceOf: CompositionUvEpi
Title: "Composition for aloxi Package Leaflet"
Description:  "Composition for aloxi Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp8c6dee4c1c691616095410343bc90da7)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - aloxi"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #da
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Oversigt over indlægssedlen 
1. Virkning og anvendelse 
2. Det skal De vide, før De begynder at tage Aloxi 
3. Sådan skal De tage Aloxi 
4. Bivirkninger 
5. Opbevaring 
6. Pakningsstørrelser og yderligere oplysninger </p>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What aloxi is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What aloxi is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Aloxi indeholder det aktive stof palonosetron. Det hører til en gruppe af lægemidler, der kaldes 
”serotonin (5HT3)- antagonister”. </p>
<p>Aloxi anvendes til voksne som en hjælp til at stoppe Deres kvalme eller opkastning, når De får 
kræftbehandlinger, som kaldes kemoterapi. </p>
<p>Det virker ved at blokere virkningen af et kemisk stof, der kaldes serotonin, som kan give kvalme eller 
medføre opkastning. </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take aloxi"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take aloxi"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag ikke Aloxi, hvis: </p>
<ul>
<li>De er allergisk over for palonosetron eller et af de øvrige indholdsstoffer i Aloxi (angivet i 
punkt 6). 
De må ikke tage Aloxi, hvis noget af det ovenstående gælder for Dem. Kontakt lægen eller 
apotekspersonalet, før De tager dette lægemiddel, hvis De er i tvivl. </li>
</ul>
<p>Advarsler og forsigtighedsregler 
Kontakt lægen eller apotekspersonalet, før De bruger Aloxi, hvis: </p>
<ul>
<li>
<p>De har en blokeret tarm eller tidligere har haft gentagne tilfælde med forstoppelse </p>
</li>
<li>
<p>De har haft hjerteproblemer, eller hvis der er tendens til hjerteproblemer i Deres familie, såsom 
ændringer af Deres hjerteslag (”QT-forlængelse”) </p>
</li>
<li>
<p>De har en ubalance af visse mineraler i blodet, som ikke er blevet behandlet, såsom kalium og 
magnesium. </p>
</li>
</ul>
<p>Børn 
Dette lægemiddel må ikke gives til børn. </p>
<p>Brug af anden medicin sammen med Aloxi 
Fortæl altid lægen eller apotekspersonalet, hvis De tager anden medicin eller har gjort det for nylig. De 
skal især fortælle dem det, hvis De tager de følgende lægemidler: </p>
<p>Lægemidler mod depression eller angst 
Fortæl det altid til lægen eller apotekspersonalet, hvis De tager lægemidler mod depression eller 
angst, herunder: 
• lægemidler, der kaldes SSRI’er (”selektive serotoningenoptagshæmmere”), såsom fluoxetin, 
paroxetin, sertralin, fluvoxamin, citalopram, escitalopram 
• lægemidler, der kaldes SNRI’er (”serotonin-noradrenalingenoptagshæmmere”), såsom 
venlafaxin, duloxetin (kan føre til udvikling af serotoninsyndrom og bør anvendes med 
forsigtighed). </p>
<p>Kontakt lægen eller apotekspersonalet, før De tager Aloxi, hvis noget af det ovenstående gælder for 
Dem (eller De er i tvivl). </p>
<p>Lægemidler, der kan påvirke Deres hjerteslag 
Fortæl det altid til lægen eller apotekspersonalet, hvis De tager lægemidler, der påvirker hjerteslaget. 
Dette skyldes, at disse lægemidler kan medføre problemer med hjerteslaget, når de tages sammen 
med Aloxi. De omfatter: 
• lægemidler mod hjerteproblemer, såsom amiodaron, nicardipin, quinidin 
• lægemidler mod infektioner, såsom moxifloxacin, erythromycin 
• lægemidler mod alvorlige psykiske problemer, såsom haloperidol, chlorpromazin, quetiapin, 
thioridazin 
• et lægemiddel mod kvalme eller opkastning kaldet domperidon. </p>
<p>Kontakt lægen eller apotekspersonalet, før De tager Aloxi, hvis noget af det ovenstående gælder for 
Dem (eller De er i tvivl). Dette skyldes, at disse lægemidler kan medføre problemer med hjerteslaget, 
når de tages sammen med Aloxi. </p>
<p>Graviditet 
Hvis De er gravid eller har mistanke om, at De er gravid, vil Deres læge ikke behandle Dem med 
Aloxi, medmindre det er strengt nødvendigt. Dette skyldes, at vi ikke ved, om Aloxi kan skade barnet. </p>
<p>Spørg Deres læge eller apotekspersonalet til råds, før De bruger dette lægemiddel, hvis De er gravid 
eller har mistanke om, at De er gravid. </p>
<p>Amning 
Det er ukendt, om Aloxi udskilles i mælk. 
Spørg Deres læge eller apotekspersonalet til råds, før De bruger dette lægemiddel, hvis De ammer. </p>
<p>Trafik- og arbejdssikkerhed 
De kan føle Dem svimmel eller træt, efter De har taget dette lægemiddel. Hvis dette sker, må De ikke 
føre motorkøretøj eller betjene værktøj eller maskiner. </p>
<p>Aloxi indeholder sorbitol og kan indeholde spor af soja 
Dette lægemiddel indeholder 7 mg sorbitol (en form for sukker) i hver kapsel. Kontakt lægen, før De 
tager dette lægemiddel, hvis lægen har fortalt Dem, at De ikke tåler visse sukkerarter. </p>
<p>Aloxi kan indeholde spor af lecithin, som udvindes af soja. De må ikke tage Aloxi, hvis De er 
overfølsom over for jordnødder eller soja. De skal konsultere Deres læge med det samme, hvis De 
bemærker et eller flere tegn på allergisk reaktion. Tegnene kan bestå i hævelse af læber, ansigt, tunge 
eller svælg, vejrtrækningsbesvær eller kollaps, og De kan også bemærke et kløende, ujævnt udslæt. </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take aloxi"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take aloxi"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag altid Aloxi nøjagtigt efter lægens eller apotekspersonalets anvisning. Er De i tvivl, så spørg lægen 
eller på apoteket. </p>
<ul>
<li>
<p>Den anbefalede dosis er én kapsel (500 mikrogram). </p>
</li>
<li>
<p>De skal normalt tage kapslen ca. 60 minutter før starten af Deres kemoterapi, </p>
</li>
<li>
<p>Dette lægemiddel kan tages med eller uden mad. </p>
</li>
</ul>
<p>De bør ikke tage Aloxi i dagene efter kemoterapi, medmindre De skal have endnu et kemoterapi-
forløb. </p>
<p>Hvis De har taget for meget Aloxi 
Hvis De mener, De har taget for meget, skal De straks fortælle det til lægen. </p>
<p>Hvis De har glemt at tage Aloxi 
Det er ikke sandsynligt, at De glemmer at tage dette lægemiddel. Hvis De mener, De har glemt at tage 
Deres dosis, skal De fortælle det til lægen med det samme. </p>
<p>Hvis De holder op med at tage Aloxi 
De må ikke holde op med at tage dette lægemiddel uden at tale med lægen. Hvis De beslutter Dem for 
ikke at tage Aloxi (eller andre lignende lægemidler), er det sandsynligt, at Deres kemoterapi vil give 
Dem kvalme eller medføre opkastning. </p>
<p>Spørg lægen eller apotekspersonalet, hvis der er noget, De er i tvivl om. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Dette lægemiddel kan som al anden medicin give bivirkninger, men ikke alle får bivirkninger. 
De følgende bivirkninger kan opstå med dette lægemiddel: </p>
<p>Alvorlige bivirkninger 
Fortæl det straks til lægen, hvis De bemærker en eller flere af de følgende alvorlige bivirkninger: </p>
<ul>
<li>Allergisk reaktion – tegnene kan omfatte hævelse af læber, ansigt, tunge eller hals, 
vejrtrækningsbesvær eller kollaps, kløende, ujævnt udslæt (nældefeber). Dette er meget sjældent: 
kan forekomme hos op til 1 ud af 10.000 personer. 
Fortæl det straks til lægen, hvis De bemærker en eller flere af de alvorlige bivirkninger anført overfor. </li>
</ul>
<p>Andre bivirkninger 
Fortæl det til lægen, hvis De bemærker en eller flere af de følgende bivirkninger: 
Almindelige: kan forekomme hos op til 1 ud af 10 personer 
• Hovedpine. </p>
<p>Ikke almindelige: kan forekomme hos op til 1 ud af 100 personer 
• Søvnbesvær 
• Stakåndethed 
• Hævelser ved øjnene 
• Unormale elektriske impulser i hjertet 
• Forstoppelse 
• Kvalme 
• Høje niveauer af pigmentet bilirubin (tegn på leverproblemer) i blodet 
• Muskelsmerter. 
Fortæl det til lægen, hvis De bemærker en eller flere af bivirkningerne anført ovenfor. </p>
<p>Indberetning af bivirkninger 
Hvis De oplever bivirkninger, bør De tale med Deres læge, sygeplejerske eller apoteket. Dette gælder 
også mulige bivirkninger, som ikke er medtaget i denne indlægsseddel. De eller Deres pårørende kan 
også indberette bivirkninger direkte til Lægemiddelstyrelsen via det nationale rapporteringssystem 
anført i Appendiks V. Ved at indrapportere bivirkninger kan De hjælpe med at fremskaffe mere 
information om sikkerheden af dette lægemiddel. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store aloxi"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store aloxi"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <ul>
<li>
<p>Opbevar lægemidlet utilgængeligt for børn. </p>
</li>
<li>
<p>Brug ikke lægemidlet efter den udløbsdato, der står på blisteren og pakningen efter EXP. 
Udløbsdatoen er den sidste dag i den nævnte måned. </p>
</li>
<li>
<p>Dette lægemiddel kræver ingen særlige forholdsregler vedrørende opbevaringen. </p>
</li>
</ul>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Aloxi indeholder: </p>
<ul>
<li>
<p>Aktivt stof: palonosetron. Hver kapsel indeholder 500 mikrogram palonosetron (som 
hydrochlorid). </p>
</li>
<li>
<p>Øvrige indholdsstoffer: glycerolmonocaprylocaproat (type I), polyglycerololeat, glycerol, renset 
vand, butylhydroxyanisol, gelatine, sorbitol, titandioxid. </p>
</li>
</ul>
<p>Udseende og pakningsstørrelser 
Aloxi 500 mikrogram bløde kapsler er ikke prægede, lys beige, uigennemsigtige, runde til ovale, bløde 
kapsler fyldt med en klar gullig opløsning. De leveres i polyamid/aluminium/PVC-blisterpakninger 
med én eller fem kapsler. </p>
<p>Ikke alle pakningsstørrelser er nødvendigvis markedsført. </p>
<p>Indehaver af markedsføringstilladelsen og fremstiller: </p>
<p>Helsinn Birex Pharmaceuticals Ltd. 
Damastown 
Mulhuddart 
Dublin Irland </p>
<p>Denne indlægsseddel blev senest ændret </p>
<p>De kan finde yderligere oplysninger om Aloxi på Det Europæiske Lægemiddelagenturs hjemmeside 
http://www.ema.europa.eu/. </p>         </div>"""      





                    
Instance: bundlepackageleaflet-en-e32583165e64f7b46ac4a8e9d8029de8
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for aloxi Package Leaflet for language en"
Description: "ePI document Bundle for aloxi Package Leaflet for language en"
Usage: #example




* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #en

// Composition
* entry[0].fullUrl = "Composition/composition-en-e32583165e64f7b46ac4a8e9d8029de8"
* entry[0].resource = composition-en-e32583165e64f7b46ac4a8e9d8029de8

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mpe32583165e64f7b46ac4a8e9d8029de8"
* entry[=].resource = mpe32583165e64f7b46ac4a8e9d8029de8
                            
                    
Instance: bundlepackageleaflet-da-e32583165e64f7b46ac4a8e9d8029de8
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for aloxi Package Leaflet for language da"
Description: "ePI document Bundle for aloxi Package Leaflet for language da"
Usage: #example




* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #da

// Composition
* entry[0].fullUrl = "Composition/composition-da-e32583165e64f7b46ac4a8e9d8029de8"
* entry[0].resource = composition-da-e32583165e64f7b46ac4a8e9d8029de8

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mpe32583165e64f7b46ac4a8e9d8029de8"
* entry[=].resource = mpe32583165e64f7b46ac4a8e9d8029de8
                            
                    



Instance: mpe32583165e64f7b46ac4a8e9d8029de8
InstanceOf: MedicinalProductDefinitionUvEpi
Title: "Medicinal Product aloxi"
Description: "aloxi"
Usage: #inline

 
* identifier[+].system = "http://ema.europa.eu/identifier"
* identifier[=].value = "EU/1/04/306/001"
* type = http://hl7.org/fhir/medicinal-product-type#MedicinalProduct "Medicinal Product"

* domain = http://hl7.org/fhir/medicinal-product-domain#Human "Human use"

* status = http://hl7.org/fhir/publication-status#active "active"


* indication = "Aloxi is indicated in adults for:"


* legalStatusOfSupply = $spor-rms#100000072084 "Medicinal product subject to medical prescription"


* name
  * productName = "aloxi"
  * type = $spor-productNamePartType-cs#220000000001 "Full name" 
  
  * part[0]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000002 "Invented name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000003 "Scientific name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000004 "Strength part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000005 "Pharmaceutical dose form part"
  
  * usage
    * country = urn:iso:std:iso:3166#DK "DK"
    * jurisdiction = urn:iso:std:iso:3166#DK "DK"
    * language = urn:ietf:bcp:47#en  "en"




RuleSet: e32583165e64f7b46ac4a8e9d8029de8ListRuleset

* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* identifier[+].system = "http://spor.ema.europa.eu/v2/medicine-name"
* identifier[=].value = "aloxi"

* status = #current
* mode = #working

* title = "List of all ePIs associated with aloxi"

* subject = Reference(mp8c6dee4c1c691616095410343bc90da7)
* subject.extension[0].url = "http://ema.europa.eu/fhir/extension/medicine-name"
* subject.extension[=].valueCoding = $100000000005#aloxi "aloxi"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/marketing-authorization-holder"
* subject.extension[=].valueCoding = $100000000005#mah-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/active-substance"
* subject.extension[=].valueCoding = $100000000005#acive-substance-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/domain"
* subject.extension[=].valueCoding = $100000000004#100000000012 "H"

* date = "2015-02-07T13:28:17Z"


* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-en-e32583165e64f7b46ac4a8e9d8029de8) // aloxi en
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "en"



* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-da-e32583165e64f7b46ac4a8e9d8029de8) // aloxi da
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "da"




Instance: List-e32583165e64f7b46ac4a8e9d8029de8
InstanceOf: List

* insert e32583165e64f7b46ac4a8e9d8029de8ListRuleset
    